University of South Florida Morsani College of Medicine, Department of Cardiovascular Sciences, Tampa, FL, United States of America; Tampa General Hospital, Tampa, FL, United States of America.
University of South Florida Morsani College of Medicine, Department of Cardiovascular Sciences, Tampa, FL, United States of America; Tampa General Hospital, Tampa, FL, United States of America.
Cardiovasc Revasc Med. 2021 Oct;31:83-88. doi: 10.1016/j.carrev.2020.11.019. Epub 2020 Nov 21.
Several case reports described acute and subacute decompensations that were reversed after percutaneous interatrial septal defect (ASD) closure. At least 30% of patients post MitraClip will continue to have a persistent ASD at 1 year. Few retrospective studies described various echocardiographic associations with persistent ASD but there is no conclusive evidence that it is the cause of a poor outcome. Conclusion: At this time routine closure of ASD post MitraClip is not recommended unless there is hemodynamic decompensation that cannot be explained by other factors.
已有数份病例报告描述了经皮房间隔缺损（ASD）封堵术后出现的急性和亚急性失代偿，但这些情况在封堵后都得到了逆转。至少有 30%的患者在接受 MitraClip 治疗 1 年后仍存在持续性 ASD。少数回顾性研究描述了持续性 ASD 与各种超声心动图的关联，但没有确凿的证据表明它是导致预后不良的原因。结论：目前不建议常规对接受 MitraClip 治疗后的 ASD 进行封堵，除非存在不能用其他因素解释的血液动力学失代偿。
